CSIMarket
 


Old Ayala Inc   (AYLA)
Other Ticker:  
 
 

AYLA's Revenue Growth by Quarter and Year

Old Ayala Inc 's Revenue results by quarter and year




AYLA Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December 0.11 1.15 1.00 0.00
III Quarter September 0.09 0.63 0.66 0.00
II Quarter June 0.04 0.76 1.05 0.00
I Quarter March 0.46 0.97 1.00 0.00
FY   0.70 3.51 3.71 0.00



AYLA Revenue fourth quarter 2022 Y/Y Growth Comment
Old Ayala Inc reported drop in Revenue in the fourth quarter 2022 by -90.87% to $ 0.11 millions, from the same quarter in 2021.
The fall in the fourth quarter 2022 Old Ayala Inc 's Revenue compares unfavorably to the Company's average Revenue decline of -43.13%.

Looking into fourth quarter 2022 results within Biotechnology & Pharmaceuticals industry 76 other companies have achieved higher Revenue growth. While Old Ayala Inc ' s Revenue meltdown of -90.87% ranks overall at the positon no. 4187 in the fourth quarter 2022.




AYLA Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December -90.87 % 15 % - -
III Quarter September -85.71 % -4.55 % - -
II Quarter June -94.74 % -27.62 % - -
I Quarter March -52.58 % -3 % - -
FY   -80.2 % -5.39 % - -

Financial Statements
Old Ayala Inc 's fourth quarter 2022 Revenue $ 0.11 millions AYLA's Income Statement
Old Ayala Inc 's fourth quarter 2021 Revenue $ 1.15 millions Quarterly AYLA's Income Statement
New: More AYLA's historic Revenue Growth >>


AYLA Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December 16.67 % 82.54 % 51.52 % -
III Quarter September 125 % -17.11 % -37.14 % -
II Quarter June -91.3 % -21.65 % 5 % -
I Quarter March -60 % -3 % - -
FY (Year on Year)   -80.2 % -5.39 % - -




Revenue fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #77
Healthcare Sector #633
Overall #4187

Revenue Y/Y Growth Statistics
High Average Low
14.14 % -43.13 % -95.01 %
(Dec 31 2021)   (Jun 30 2022)
Revenue fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #77
Healthcare Sector #633
Overall #4187
Revenue Y/Y Growth Statistics
High Average Low
14.14 % -43.13 % -95.01 %
(Dec 31 2021)   (Jun 30 2022)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Old Ayala Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
139.47 % 5.79 % -91.7 %
(Sep 30 2022)  


AYLA's IV. Quarter Q/Q Revenue Comment
Old Ayala Inc achieved in the IV. Quarter 2022 above company average sequential Revenue jump of 16.67%, to $ 0.11 millions, from $0.09 millions in the third quarter.

Within Biotechnology & Pharmaceuticals industry 35 other companies have achieved higher Revenue quarter on quarter growth. While Old Ayala Inc 's Revenue growth quarter on quarter, overall rank is 620.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #36
Healthcare Sector #151
Overall #620
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #36
Healthcare Sector #151
Overall #620
Revenue Q/Q Growth Statistics
High Average Low
139.47 % 5.79 % -91.7 %
(Sep 30 2022)  


AYLA's IV. Quarter Q/Q Revenue Comment
Old Ayala Inc achieved in the IV. Quarter 2022 above company average sequential Revenue jump of 16.67%, to $ 0.11 millions, from $0.09 millions in the third quarter.

Within Biotechnology & Pharmaceuticals industry 35 other companies have achieved higher Revenue quarter on quarter growth. While Old Ayala Inc 's Revenue growth quarter on quarter, overall rank is 620.


Old Ayala Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
Cumulative Revenue 12 Months Ending $ 0.69 $ 1.73 $ 2.27 $ 2.99 $ 3.51
Y / Y Revenue Growth (TTM) -80.26 % -48.48 % -33.26 % -18.77 % -5.45 %
Year on Year Revenue Growth Overall Ranking # 3271 # 2439 # 2850 # 2916 # 3281
Seqeuential Revenue Change (TTM) -60.07 % -23.56 % -24.18 % -14.72 % 4.22 %
Seq. Revenue Growth (TTM) Overall Ranking # 2619 # 2723 # 3889 # 3263 # 3047




Cumulative Revenue growth Comment
Old Ayala Inc 's cumulative 12 months Revenue continue to drop, but on the faster rate at -80.26% year on year, at Dec 31 2022 compare to the -48.48% decrease at Sep 30 2022. If the Old Ayala Inc 's fiscal year would end at Dec 31 2022, annual Revenue would be $1 millions.

In the Healthcare sector 443 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2439 to 3271.

Revenue TTM Q/Q Growth Statistics
High Average Low
-5.45 %
-37.25 %
-80.26 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 39
Healthcare Sector # 444
Overall # 3271

Revenue TTM Y/Y Growth Statistics
High Average Low
-5.45 %
-37.25 %
-80.26 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 39
Sector # 341
S&P 500 # 2619
Cumulative Revenue growth Comment
Old Ayala Inc 's cumulative 12 months Revenue continue to drop, but on the faster rate at -80.26% year on year, at Dec 31 2022 compare to the -48.48% decrease at Sep 30 2022. If the Old Ayala Inc 's fiscal year would end at Dec 31 2022, annual Revenue would be $1 millions.

In the Healthcare sector 443 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2439 to 3271.

Revenue TTM Q/Q Growth Statistics
High Average Low
-5.45 %
-37.25 %
-80.26 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 39
Healthcare Sector # 444
Overall # 3271

Revenue TTM Y/Y Growth Statistics
High Average Low
-5.45 %
-37.25 %
-80.26 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 39
Sector # 341
S&P 500 # 2619




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
AYLA's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for AYLA's Competitors
Revenue Growth for Old Ayala Inc 's Suppliers
Revenue Growth for AYLA's Customers

You may also want to know
AYLA's Annual Growth Rates AYLA's Profitability Ratios AYLA's Asset Turnover Ratio AYLA's Dividend Growth
AYLA's Roe AYLA's Valuation Ratios AYLA's Financial Strength Ratios AYLA's Dividend Payout Ratio
AYLA's Roa AYLA's Inventory Turnover Ratio AYLA's Growth Rates AYLA's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2022
Amgen Inc -0.10%$ -0.102 millions
Bausch Health Companies Inc -0.14%$ -0.137 millions
Bio rad Laboratories Inc -0.34%$ -0.339 millions
National Research Corporation-0.40%$ -0.402 millions
Asensus Surgical Inc -0.48%$ -0.485 millions
Teleflex Incorporated-0.51%$ -0.514 millions
Elite Pharmaceuticals Inc -0.62%$ -0.619 millions
Meihua International Medical Technologies Co Ltd -0.66%$ -0.665 millions
Ambrx Biopharma Inc -0.71%$ -0.711 millions
Chemed Corporation-0.85%$ -0.851 millions
Vycor Medical Inc -0.90%$ -0.899 millions
Fonar Corporation-0.91%$ -0.911 millions
Davita Inc -0.92%$ -0.920 millions
Syneos Health Inc -0.98%$ -0.984 millions
Reshape Lifesciences Inc -1.02%$ -1.018 millions
Accuray Incorporated-1.30%$ -1.303 millions
Pliant Therapeutics Inc -1.70%$ -1.701 millions
Royalty Pharma Plc-1.73%$ -1.729 millions
Precipio inc -1.81%$ -1.807 millions
Integra Lifesciences Holdings Corp-1.85%$ -1.850 millions
Novartis Ag-1.98%$ -1.984 millions
Theravance Biopharma inc -1.99%$ -1.987 millions
Uphealth Inc -2.20%$ -2.203 millions
Orthofix Medical Inc -2.27%$ -2.267 millions
Travere Therapeutics Inc -2.41%$ -2.412 millions
Heska Corporation-2.54%$ -2.542 millions
Sangamo Therapeutics Inc -2.70%$ -2.701 millions
Glaukos Corp-2.75%$ -2.748 millions
Community Health Systems Inc -2.85%$ -2.846 millions
Invitae Corporation-2.91%$ -2.908 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com